San Diego-primarily based Viking Therapeutics marked alone as a serious competitor while in the weight loss drug industry in February right after revealing promising information from the mid-stage demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided to be a weekly injection As well a